Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Axogen, Inc. Director's Dealing 2012

Jan 24, 2012

32414_dirs_2012-01-24_76b7cec5-977e-4fdd-bd43-32059f6ee4ed.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AxoGen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2011-12-23

Reporting Person: Friedman Mark Louis (Vice President of RA/QA)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2011-12-23 Common Stock M 3727 $0.27 Acquired 3727 Direct
2011-12-23 Common Stock M 1028 $0.27 Acquired 4755 Direct
2011-12-23 Common Stock M 601 $0.27 Acquired 5356 Direct
2011-12-23 Common Stock M 309 $0.27 Acquired 5665 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2011-12-23 Employee Stock Option (right to buy) $0.27 M 3727 Disposed 2016-10-17 Common Stock (3727) Direct
2011-12-23 Employee Stock Option (right to buy) $0.27 M 1028 Disposed 2017-04-27 Common Stock (1028) Direct
2011-12-23 Employee Stock Option (right to buy) $0.27 M 601 Disposed 2017-12-06 common stock (601) Direct
2011-12-23 Employee Stock Option (right to buy) $0.27 M 309 Disposed 2018-11-18 common stock (309) Direct

Footnotes

F1: Acquired through exercise of vested portion of stock options.

F2: These options vest semi-annually over four years from the date of grant.